Sonnet Biotherapeutics Holdings, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
SCHEDULE: Republic Digital's Stake in Sonnet BioTherapeutics Falls Below 5% Following Share Increase
Republic Digital Opportunistic Digital Assets Master Fund, Ltd. and Joseph Naggar's beneficial ownership in Sonnet BioTherapeutics Holdings, Inc. decreased to 4.2% after an increase in the issuer's outstanding common stock.